DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • October 8th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York
Contract Type FiledOctober 8th, 2024 Company Industry JurisdictionThis DEBT-FOR-EQUITY EXCHANGE AGREEMENT (this “Agreement”), dated as of September 30, 2024 (the “Effective Date”) is made by and between Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada (the “Company”), and Newcourt SPAC Sponsor, LLC (“Lender”).
FIRST ADDENDUM TO THE SHARE PURCHASE AND SALE AGREEMENT Between PSYENCE GROUP INC. (the "Seller") and PSYENCE BIOMEDICAL LTD. (the "Purchaser") and PSYENCE LABS LTD. (the "Company") (collectively, the "Parties")The Share Purchase and Sale Agreement • October 8th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 8th, 2024 Company Industry